Keywords: اپوپروستونول; Diagnosis; Epoprostenol; High-resolution computed tomography; Pulmonary arterial hypertension-targeted therapy; Pulmonary hypertension;
مقالات ISI اپوپروستونول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Pulmonary circulation; Right heart catheterization; Adenosine; Epoprostenol; Pulmonary vasodilation; BP; blood pressure; CI; cardiac index; CO; cardiac output; ESC; European Society of Cardiology; HIV; human immunodeficien
Keywords: اپوپروستونول; Pulmonary veno-occlusive disease; Pulmonary hypertension; Lung biopsy; Epoprostenol;
Keywords: اپوپروستونول; Epoprostenol; Hemodynamics; HRCT; Pulmonary arterial pressure; Survival; Treatment;
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Epoprostenol; Dose titration; Pulmonary artery pressure; Survival;
Keywords: اپوپروستونول; cardiac surgery; milrinone; epoprostenol; prostacyclin; cardiopulmonary bypass; pulmonary hypertension
Keywords: اپوپروستونول; Anesthesia; Obstetric; Scleroderma; CREST syndrome; Pulmonary hypertension; Epoprostenol; Cesarean delivery;
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Epoprostenol; Combination therapy; Survival;
Keywords: اپوپروستونول; sildenafil; epoprostenol; pulmonary arterial hypertension; survival; clinical trial;
Keywords: اپوپروستونول; Epoprostenol; Nitric oxide; Hypoxemia; ARDS; Pulmonary vasodilator;
Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome
Keywords: اپوپروستونول; Steroid therapy; Ground glass opacity; Inter-lobular septal thickening; Epoprostenol; Acute respiratory distress syndrome; Trans-capillary fluid leakage;
Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations?
Keywords: اپوپروستونول; Inhaled Nitric Oxide; inhaled prostacyclin; epoprostenol; pulmonary artery hypertension; right ventricular failure; heart transplant; lung transplant; left ventricular assist device;
Notable alkaline tolerance of Kocuria marina isolate from blood of a pediatric patient with continuous intravenous epoprostenol therapy
Keywords: اپوپروستونول; Kocuria marina; Alkaline tolerance; Alkalophilic; Epoprostenol; Catheter-related blood stream infection;
Featured contentOriginal researchComparative Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Profiles of 3 Different Formulations of Epoprostenol Sodium for Injection in Healthy Men
Keywords: اپوپروستونول; bioequivalence; epoprostenol; hemodynamics; pharmacokinetic profile; prostacyclin;
Antithrombotic strategies in children receiving long-term Berlin Heart EXCOR ventricular assist device therapy
Keywords: اپوپروستونول; ventricular assist device; thromboembolic events; bivalirudin; epoprostenol; antithrombotic; anticoagulation;
Children with pulmonary arterial hypertension and prostanoid therapy: Long-term hemodynamics
Keywords: اپوپروستونول; pediatric patients; pulmonary arterial hypertension; epoprostenol; treprostinil; hemodynamics;
Impact of switching from epoprostenol to IV treprostinil on treatment satisfaction and quality of life in patients with pulmonary hypertension
Keywords: اپوپروستونول; Prostacyclin analog; Pulmonary hypertension; Epoprostenol; Transition; Treprostinil; Quality of life
Parenteral and Inhaled Prostanoid Therapy in the Treatment of Pulmonary Arterial Hypertension
Keywords: اپوپروستونول; Epoprostenol; Iloprost; Inhaled therapy; Intravenous therapy; Parenteral therapy; Prostacyclins; Prostanoids; Treprostinil;
Pulmonary Hypertension in Patients Undergoing Cardiac Surgery: Pathophysiology, Perioperative Management, and Outcomes
Keywords: اپوپروستونول; pulmonary hypertension; pulmonary vascular resistance; right ventricle; heart failure; cardiac surgery; nitric oxide; epoprostenol; transesophageal echocardiography; lung transplantation;
Pulmonary hypertension associated with veno-occlusive disease in systemic sclerosis: Insight into the mechanism of resistance to vasodilator
Keywords: اپوپروستونول; Pulmonary veno-occlusive disease; Pulmonary hypertension; Pulmonary arterial hypertension; Epoprostenol
Pulmonary arterial hypertension due to pulmonary veno-occlusive disease in systemic sclerosis: Importance of early diagnosis and cautious use of pulmonary vasodilator therapy
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Pulmonary veno-occlusive disease; Systemic sclerosis; High resolution computed tomography; Epoprostenol;
Alta incidencia de bacteriemia por bacilos gramnegativos en pacientes con hipertensión pulmonar tratados con treprostinil por vía intravenosa
Keywords: اپوپروستونول; Bacteriemia; Epoprostenol; Hipertensión arterial pulmonar; Prostanoide; TreprostinilBacteremia; Epoprostenol; Pulmonary arterial hypertension; Prostanoid; Treprostinil
High Incidence of Bloodstream Infection Due to Gram-negative Bacilli in Patients With Pulmonary Hypertension Receiving Intravenous Treprostinil
Keywords: اپوپروستونول; Bacteremia; Epoprostenol; Pulmonary arterial hypertension; Prostanoid; TreprostinilBacteriemia; Epoprostenol; Hipertensión arterial pulmonar; Prostanoide; Treprostinil
Epoprostenol-Induced Hypersplenism in Portopulmonary Hypertension
Keywords: اپوپروستونول; Epoprostenol; Portopulmonary hypertension; Hypersplenism; Splenomegaly; Pancytopenia;
Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Prostacyclin; Treprostinil; Epoprostenol; Intravenous;
The experiences of patients with pulmonary arterial hypertension receiving continuous intravenous infusion of epoprostenol (Flolan) and their support persons
Keywords: اپوپروستونول; Epoprostenol; Pulmonary arterial hypertension; Qualitative; Resilience; Support persons; Technology
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referral
Keywords: اپوپروستونول; pulmonary arterial hypertension; prostanoids; epoprostenol; treprostinil; survival;
Intravenous epoprostenol versus high dose inhaled iloprost for long-term treatment of pulmonary hypertension
Keywords: اپوپروستونول; Pulmonary hypertension; Epoprostenol; High dose inhaled iloprost; Long-term treatment
Epoprostenol inhibits human platelet-leukocyte mixed conjugate and platelet microparticle formation in whole blood
Keywords: اپوپروستونول; Epoprostenol; Mixed platelet-leukocyte conjugates; Platelet microparticles; PFA-100; Collagen-ADP platelet stimulation; VASP phosphorylation
Treatment of pulmonary arterial hypertension: The role of prostacyclin and prostaglandin analogs
Keywords: اپوپروستونول; Epoprostenol; Iloprost; Right heart failure; Treprostinil; 6-Minute walk test distance
Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey
Keywords: اپوپروستونول; pulmonary hypertension; pulmonary arterial hypertension; prostacyclin; epoprostenol; treprostinil;
Long-term outcomes in pulmonary arterial hypertension in the first-line epoprostenol or first-line bosentan era
Keywords: اپوپروستونول; pulmonary arterial hypertension; prostacyclin; endothelin-receptor antagonist; bosentan; epoprostenol;
Medical and non-medical considerations for the outpatient management of children with pulmonary arterial hypertension
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Intravenous prostacyclin therapy; Epoprostenol; Trepostinil
Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension
Keywords: اپوپروستونول; epoprostenol; pulmonary hypertension; thrombocytopeniaCI, confidence interval; OR, odds ratio; PAH, pulmonary arterial hypertension; Svo2, mixed venous oxygen saturation
Vaso-active therapy can improve 6-min walk distance in patients with pulmonary hypertension and fibrotic interstitial lung disease
Keywords: اپوپروستونول; Pulmonary hypertension; Pulmonary fibrosis; Epoprostenol; Bosentan; Therapeutics
Right Ventricular Pressure Waveform and Wave Reflection Analysis in Patients With Pulmonary Arterial Hypertension
Keywords: اپوپروستونول; cardiac output; epoprostenol; pulmonary arterial hypertension; right ventricular pressure; wave reflectionAP, augmented pressure; dP/dtmax, maximum derivative of pressure measured over time; dP/dtmin, minimum derivative of pressure measured over time; eCI
Ventilation–perfusion relationships in pulmonary arterial hypertension: Effect of intravenous and inhaled prostacyclin treatment
Keywords: اپوپروستونول; V˙A/Q˙ Ratios; Multiple inert-gas elimination technique; Shunt; Mixed venous oxygenation; Pulmonary arterial hypertension; Epoprostenol; Inhaled iloprost; Hypoxaemia
Medical Therapy for Pulmonary Arterial Hypertension : Updated ACCP Evidence-Based Clinical Practice Guidelines
Keywords: اپوپروستونول; anticoagulation; arginine; beraprost; bosentan; calcium-channel blockers; endothelin; endothelin receptor antagonist; epoprostenol; idiopathic pulmonary arterial hypertension; iloprost; medical therapy; oxygen; primary pulmonary hypertension; prostacyclin
Conversion to Bosentan From Prostacyclin Infusion Therapy in Pulmonary Arterial Hypertension : A Pilot Study
Keywords: اپوپروستونول; bosentan; epoprostenol; pulmonary arterial hypertension; transitions; treprostinilCI, confidence interval; HR, hazard ratio; NYHA, New York Heart Association; PA, pulmonary artery; PAH, pulmonary arterial hypertension; PGI2, prostaglandin I2; PVR, pulmona
Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension
Keywords: اپوپروستونول; Pulmonary arterial hypertension; Sildenafil; Nitric oxide; Epoprostenol; Vasodilator testing;